Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Plumino Precision Fermentation Japan Co. Ltd. currently has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. Both actions are being processed within 1 distinct art unit, but they involve 2 distinct examiners. This suggests that while the technical field is narrow, the company is interacting with multiple perspectives within that single unit. This structure allows for some technical consistency while requiring adaptation to different examiner preferences.
Emily Fay Eix is the busiest examiner for the portfolio, managing 1 pending office action. Having 2 distinct examiners in 1 distinct art unit for only 2 pending actions indicates a high degree of examiner variety relative to the technical scope. Practitioners should be prepared to address different examiner styles while maintaining a consistent technical argument within the same art unit. This situation provides an opportunity to see how different examiners within the same unit interpret the company's core fermentation technologies.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EIX, EMILY FAY | 1 | 45.5% | +78.3% |
| ZINGARELLI, SANDRA | 1 | 6.9% | +46.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18264666 | PROTEIN HAVING FUCOSE-CONTAINING SUGAR TRANSPORTING ACTIVITY, AND METHOD FOR PRODUCING FUCOSE-CONTAINING SUGAR | ZINGARELLI, SANDRA | 61d |
| 18547082 | MODIFIED PROTEIN HAVING ALPHA1,2-FUCOSYLTRANSFERASE ACTIVITY AND METHOD FOR PRODUCING FUCOSE-CONTAINING CARBOHYDRATE | EIX, EMILY FAY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18264666 | PROTEIN HAVING FUCOSE-CONTAINING SUGAR TRANSPORTING ACTIVITY, AND METHOD FOR PRODUCING FUCOSE-CONTAINING SUGAR | ZINGARELLI, SANDRA | 61d |
| 18547082 | MODIFIED PROTEIN HAVING ALPHA1,2-FUCOSYLTRANSFERASE ACTIVITY AND METHOD FOR PRODUCING FUCOSE-CONTAINING CARBOHYDRATE | EIX, EMILY FAY | — |
| Art Unit | Apps |
|---|---|
| 1653 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18547082 | MODIFIED PROTEIN HAVING ALPHA1,2-FUCOSYLTRANSFERASE ACTIVITY AND METHOD FOR PRODUCING FUCOSE-CONTAINING CARBOHYDRATE | EIX, EMILY FAY | 1653 | §102§103§112 | Non-Final OA | — | Pending | Aug 18, 2023 |
| 18264666 | PROTEIN HAVING FUCOSE-CONTAINING SUGAR TRANSPORTING ACTIVITY, AND METHOD FOR PRODUCING FUCOSE-CONTAINING SUGAR | ZINGARELLI, SANDRA | 1653 | §102 | Final Rejection | 61d | Pending | Aug 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial